IRIS Accounts Production v23.3.1.45 08321411 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh083214112022-12-31083214112023-12-31083214112023-01-012023-12-31083214112021-12-31083214112022-01-012022-12-31083214112022-12-3108321411ns10:Originalns15:EnglandWales2023-01-012023-12-3108321411ns14:PoundSterlingns10:Original2023-01-012023-12-3108321411ns10:Originalns10:Director12023-01-012023-12-3108321411ns10:Original2023-01-012023-12-3108321411ns10:Original2023-12-3108321411ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3108321411ns10:Originalns10:Micro-entities2023-01-012023-12-3108321411ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3108321411ns10:Originalns10:FullAccounts2023-01-012023-12-3108321411ns10:Originalns10:Director22023-01-012023-12-3108321411ns10:Originalns10:Director32023-01-012023-12-3108321411ns10:CompanySecretary1ns10:Original2023-01-012023-12-3108321411ns10:Originalns10:RegisteredOffice2023-01-012023-12-3108321411ns10:Original2022-12-3108321411ns10:Originalns5:CurrentFinancialInstruments2023-12-3108321411ns10:Originalns5:CurrentFinancialInstruments2022-12-3108321411ns10:Original2022-01-012022-12-3108321411ns10:Original1ns10:Director12022-12-3108321411ns10:Original1ns10:Director12021-12-3108321411ns10:Original1ns10:Director12023-01-012023-12-3108321411ns10:Original1ns10:Director12022-01-012022-12-3108321411ns10:Original1ns10:Director12023-12-3108321411ns10:Original1ns10:Director12022-12-3108321411ns10:Originalns10:Director332022-12-3108321411ns10:Originalns10:Director332021-12-3108321411ns10:Originalns10:Director332023-01-012023-12-3108321411ns10:Originalns10:Director332022-01-012022-12-3108321411ns10:Originalns10:Director332023-12-3108321411ns10:Originalns10:Director332022-12-31
REGISTERED NUMBER: 08321411 (England and Wales)















South West Dermatology Limited

Unaudited Financial Statements for the Year Ended 31 December 2023






South West Dermatology Limited (by shares) (Registered number: 08321411)






Contents of the Financial Statements
for the year ended 31 December 2023




Page

Company Information 1

Balance Sheet 2


South West Dermatology Limited (by shares)

Company Information
for the year ended 31 December 2023







DIRECTORS: T Chave
U S Brudnik
C I Allen





SECRETARY: T Chave





REGISTERED OFFICE: One New Street
Wells
Somerset
BA5 2LA





REGISTERED NUMBER: 08321411 (England and Wales)





ACCOUNTANTS: Webb & Co Ltd
Accountants and Business Advisers
One New Street
Wells
Somerset
BA5 2LA

South West Dermatology Limited (by shares) (Registered number: 08321411)

Balance Sheet
31 December 2023

2023 2022
£    £   
CURRENT ASSETS 930 72,748

CREDITORS
Amounts falling due within one year (900 ) (7,506 )
NET CURRENT ASSETS 30 65,242
TOTAL ASSETS LESS CURRENT
LIABILITIES

30

65,242

CAPITAL AND RESERVES 30 65,242

NOTES TO THE FINANCIAL STATEMENTS

1. CEASED TRADING

Company ceased to trade 31 December 2023.

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2022 - 2 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2023 and 31 December 2022:

2023 2022
£    £   
T Chave
Balance outstanding at start of year - -
Amounts advanced 125 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 125 -

C I Allen
Balance outstanding at start of year - -
Amounts advanced 530 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 530 -



South West Dermatology Limited (by shares) (Registered number: 08321411)

Balance Sheet - continued
31 December 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 22 February 2024 and were signed on its behalf by:





T Chave - Director